Curexo Inc. (KOSDAQ:060280)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,070.00
+90.00 (1.13%)
Apr 1, 2025, 3:30 PM KST

Curexo Revenue

Curexo had revenue of 7.39B KRW in the quarter ending September 30, 2016, with 4.35% growth. This brings the company's revenue in the last twelve months to 27.85B, down -3.00% year-over-year. In the year 2015, Curexo had annual revenue of 27.53B with 5.33% growth.

Revenue (ttm)
27.85B
Revenue Growth
-3.00%
P/S Ratio
7.70
Revenue / Employee
960.27M
Employees
29
Market Cap
331.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 201527.53B1.39B5.33%
Dec 31, 201426.14B-4.95B-15.93%
Dec 31, 201331.09B6.81B28.05%
Dec 31, 201224.28B13.74B130.32%
Dec 31, 201110.54B-21.61B-67.21%
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 3,557.30B
ALTEOGEN 102.85B
Yuhan 2,067.79B
SK Biopharmaceuticals 547.60B
HLB Co., Ltd. 51.92B
Sam Chun Dang Pharm. 210.92B
PharmaResearch 350.12B
Revenue Rankings